Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy patients--a Randomized Double Blind Clinical Trial

NCT02283450 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT02283450
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02283450 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Regulation of Immunological Cytokines by Qiliqiangxin Capsule in Dilated Cardiomyopathy patients--a Randomized Double Blind Clinical Trial
Lead sponsor
Harbin Medical University
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
April 30, 2014
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure